Hikma Pharmaceuticals
HIK.L
#2476
Rank
NZ$9.41 B
Marketcap
$4,272
Share price
0.95%
Change (1 day)
11,129.71%
Change (1 year)

Earnings for Hikma Pharmaceuticals (HIK.L)

Earnings in 2023: NZ$0.46 Billion

According to Hikma Pharmaceuticals 's latest financial reports the company's current earnings are NZ$2.87 Billion. In 2023 the company made an earning of NZ$0.46 Billion, an increase over its 2022 earnings that were of NZ$0.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hikma Pharmaceuticals from 2002 to 2023

Annual earnings

Year Earnings Change
2023NZ$0.46 B20.6%
2022NZ$0.38 B-57.17%
2021NZ$0.90 B-2.51%
2020NZ$0.93 B13.65%
2019NZ$0.82 B67.58%
2018NZ$0.48 B-139.7%
2017-NZ$1.24 Billion-451.43%
2016NZ$0.35 B-33.96%
2015NZ$0.53 B-12.15%
2014NZ$0.60 B21.48%
2013NZ$0.49 B125.76%
2012NZ$0.22 B40.59%
2011NZ$0.15 B-22.39%
2010NZ$0.20 B27.63%
2009NZ$0.15 B48.03%
2008NZ$0.10 B-23.58%
2007NZ$0.13 B10.84%
2006NZ$0.12 B17.37%
2005NZ$0.10 B9.12%
2004NZ$98.6 M98.92%
2003NZ$49.57 M55.38%
2002NZ$31.9 M